{"doi":"10.1002/jmv.28008","title":"Association between COVID‐19 and telomere length: A bidirectional Mendelian randomization study","abstract":"<jats:title>Abstract</jats:title><jats:p>Several traditional observational studies suggested an association between COVID‐19 and leukocyte telomere length (LTL), a biomarker for biological age. However, whether there was a causal association between them remained unclear. We aimed to investigate whether genetically predicted COVID‐19 is related to the risk of LTL, and vice versa. We performed bidirectional Mendelian randomization (MR) study using summary statistics from the genome‐wide association studies of critically ill COVID‐19 (<jats:italic>n</jats:italic> = 1 388 342) and LTL (<jats:italic>n</jats:italic> = 472 174) of European ancestry. The random‐effects inverse‐variance weighted estimation method was applied as the primary method with several other estimators as complementary methods. Using six single‐nucleotide polymorphisms (SNPs) of genome‐wide significance as instrumental variables for critically ill COVID‐19, we did not find a significant association of COVID‐19 on LTL (<jats:italic>β</jats:italic> = 0.0075, 95% confidence interval [CI]: −0.018 to 0.021, <jats:italic>p</jats:italic> = 0.733). Likewise, using 97 SNPs of genome‐wide significance as instrumental variables for LTL, we did not find a significant association of LTL on COVID‐19 (odds ratio = 1.00, 95% CI: 0.79–1.28, <jats:italic>p</jats:italic> = 0.973). Comparable results were obtained using MR‐Egger regression, weighted median, and weighted mode approaches. We did not find evidence to support a causal association between COVID‐19 and LTL in either direction.</jats:p>","journal":"Journal of Medical Virology","year":2022,"id":639548,"datarank":2.570266913724329,"base_score":4.727387818712341,"endowment":4.727387818712341,"self_citation_contribution":0.7091081728068512,"citation_network_contribution":1.8611587409174775,"self_endowment_contribution":0.7091081728068512,"citer_contribution":1.8611587409174775,"corpus_percentile":null,"corpus_rank":null,"citation_count":112,"citer_count":100,"citers_with_citation_signal":67,"citers_with_endowment":67,"datacite_reuse_total":25,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1661714,"name":"Siqi Lin","orcid":null,"position":1,"is_corresponding":false},{"id":1661715,"name":"Junting He","orcid":null,"position":2,"is_corresponding":false},{"id":348529,"name":"Qi Wang","orcid":"0000-0003-0858-9393","position":3,"is_corresponding":false},{"id":999965,"name":"Yiqiang Zhan","orcid":"0000-0001-5815-9725","position":4,"is_corresponding":false},{"id":1661713,"name":"Danqi Huang","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Association between COVID‐19 and telomere length: A bidirectional Mendelian randomization study","abstract":"<jats:title>Abstract</jats:title><jats:p>Several traditional observational studies suggested an association between COVID‐19 and leukocyte telomere length (LTL), a biomarker for biological age. However, whether there was a causal association between them remained unclear. We aimed to investigate whether genetically predicted COVID‐19 is related to the risk of LTL, and vice versa. We performed bidirectional Mendelian randomization (MR) study using summary statistics from the genome‐wide association studies of critically ill COVID‐19 (<jats:italic>n</jats:italic> = 1 388 342) and LTL (<jats:italic>n</jats:italic> = 472 174) of European ancestry. The random‐effects inverse‐variance weighted estimation method was applied as the primary method with several other estimators as complementary methods. Using six single‐nucleotide polymorphisms (SNPs) of genome‐wide significance as instrumental variables for critically ill COVID‐19, we did not find a significant association of COVID‐19 on LTL (<jats:italic>β</jats:italic> = 0.0075, 95% confidence interval [CI]: −0.018 to 0.021, <jats:italic>p</jats:italic> = 0.733). Likewise, using 97 SNPs of genome‐wide significance as instrumental variables for LTL, we did not find a significant association of LTL on COVID‐19 (odds ratio = 1.00, 95% CI: 0.79–1.28, <jats:italic>p</jats:italic> = 0.973). Comparable results were obtained using MR‐Egger regression, weighted median, and weighted mode approaches. We did not find evidence to support a causal association between COVID‐19 and LTL in either direction.</jats:p>","is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":25,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"35854470","pmcid":"PMC9349767","openalex_id":null,"authors":[],"funders":[{"funder_name":"National Natural Science Foundation of China","grant_id":"","title":null},{"funder_name":"Sun Yat-sen University","grant_id":"","title":null}],"total_grants":2,"fwci":null,"citation_percentile":null,"influential_citations":0,"citation_trend":[],"oa_status":"hybrid","license":"public-domain","oa_locations":[{"url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.28008","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.28008","host_type":"publisher"},{"url":"https://onlinelibrary.wiley.com/doi/full-xml/10.1002/jmv.28008","host_type":"publisher"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9349767","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC9349767","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC9349767?pdf=render","host_type":"Europe_PMC"}],"fields_of_study":[],"mesh_terms":["Telomere","Humans","Critical Illness","Polymorphism, Single Nucleotide","Genome-Wide Association Study","Mendelian Randomization Analysis","COVID-19"],"keywords":["Telomere Length.","Covid-19","Bidirectional Two-sample Mendelian Randomization"],"sdg_mappings":[],"linked_datasets":[{"doi":"10.6084/m9.figshare.25572623.v1","title":"Additional file 1 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25572623","title":"Additional file 1 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25632963.v1","title":"Additional file 1 of Osteoarthritis and hypertension: observational and Mendelian randomization analyses","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.25632963","title":"Additional file 1 of Osteoarthritis and hypertension: observational and Mendelian randomization analyses","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26592563.v1","title":"Additional file 1 of Association between leukocyte telomere length and COVID-19 severity","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26592563","title":"Additional file 1 of Association between leukocyte telomere length and COVID-19 severity","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26624362.v1","title":"Additional file 1 of Effects of iron homeostasis on epigenetic age acceleration: a two-sample Mendelian randomization study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26624362","title":"Additional file 1 of Effects of iron homeostasis on epigenetic age acceleration: a two-sample Mendelian randomization study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26672562.v1","title":"Additional file 1 of SARS-CoV-2 neurovascular invasion supported by Mendelian randomization","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26672562","title":"Additional file 1 of SARS-CoV-2 neurovascular invasion supported by Mendelian randomization","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26672565.v1","title":"Additional file 2 of SARS-CoV-2 neurovascular invasion supported by Mendelian randomization","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26672565","title":"Additional file 2 of SARS-CoV-2 neurovascular invasion supported by Mendelian randomization","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.26704452.v1","title":"Additional file 5 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.26704458","title":"Additional file 7 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.26704461.v1","title":"Additional file 8 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.26704464","title":"Additional file 9 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.26704452","title":"Additional file 5 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.26704455","title":"Additional file 6 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.26704455.v1","title":"Additional file 6 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.26704458.v1","title":"Additional file 7 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.26704461","title":"Additional file 8 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.26704464.v1","title":"Additional file 9 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.25572698.v1","title":"Additional file 2 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.26704446.v1","title":"Additional file 3 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study","publisher":"figshare","resource_type":"Dataset"},{"doi":"10.6084/m9.figshare.25572698","title":"Additional file 2 of Interaction of immune cells with renal cancer development: Mendelian randomization (MR) study","publisher":"figshare","resource_type":"Dataset"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-07T00:47:39.115446Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}